Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...
Mitsubishi Tanabe Pharma, for over 500 billion yen . This move aligns with Mitsubishi Chemical's strategy to streamline its operations and concentrate on core sectors such as vehicle ...
A deal could value Mitsubishi Tanabe Pharma at more than ¥500 billion yen ($3.3 billion), the people said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results